Lexaria Bioscience Corp. SEC filings LEXX
Lexaria Bioscience Corp. has 1,000 filings in SEC EDGAR's recent list, going back to Aug 25, 2009. Its latest annual report, Form 10-K, was filed on Nov 28, 2025 for the period ended Aug 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 13, 2026, covering the quarter ended May 31, 2026. The most recent current report (Form 8-K) was filed on Sep 9, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on August 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Nov 28, 2025 | Aug 31, 2025 |
| 10-K | Annual report | Nov 26, 2024 | Aug 31, 2024 |
| 10-K | Annual report | Nov 20, 2023 | Aug 31, 2023 |
| 10-K/A | Amended annual report | Dec 6, 2022 | Aug 31, 2022 |
| 10-K | Annual report | Nov 28, 2022 | Aug 31, 2022 |
| 10-K | Annual report | Nov 29, 2021 | Aug 31, 2021 |
| 10-K | Annual report | Oct 15, 2020 | Aug 31, 2020 |
| 10-K | Annual report | Nov 14, 2019 | Aug 31, 2019 |
| 10-K | Annual report | Nov 14, 2018 | Aug 31, 2018 |
| 10-K | Annual report | Nov 27, 2017 | Aug 31, 2017 |
| 10-K | Annual report | Nov 29, 2016 | Aug 31, 2016 |
| 10-K | Annual report | Nov 27, 2015 | Aug 31, 2015 |
| 10-KT | Transition report | Dec 9, 2014 | Aug 31, 2014 |
| 10-K | Annual report | Jan 24, 2014 | Oct 31, 2013 |
| 10-K | Annual report | Jan 29, 2013 | Oct 31, 2012 |
| 10-K/A | Amended annual report | Mar 15, 2012 | Oct 31, 2011 |
| 10-K/A | Amended annual report | Jan 31, 2012 | Oct 31, 2011 |
| 10-K | Annual report | Jan 30, 2012 | Oct 31, 2011 |
| 10-K/A | Amended annual report | Feb 8, 2011 | Oct 31, 2010 |
| 10-K/A | Amended annual report | Feb 1, 2011 | Oct 31, 2010 |
| 10-K | Annual report | Jan 31, 2011 | Oct 31, 2010 |
| 10-K | Annual report | Jan 20, 2010 | Oct 31, 2009 |
| 10-K/A | Amended annual report | Nov 18, 2009 | Oct 31, 2008 |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LEXX (Nasdaq)
- Fiscal year ends
- August 31
- Incorporated in
- NV
- Headquarters
- Kelowna, British Columbia, Canada
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1348362
- Former names
- Lexaria Corp. (until May 11, 2016); LEXARIA CORP. (until May 11, 2016)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.